ReeLabs is honoured to be felicitated by the prestigious Limca Book of Records as the first and only cell based, FDA approved, clinical trial in India to cure moderate to severe COVID-19 using a patented (patent granted in US, EU, UK and India) product. We are firmly committed to continue our pathbreaking research to mitigate ailments and save lives.